Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Shares Repurchased (2016 - 2025)

United Therapeutics' Shares Repurchased history spans 13 years, with the latest figure at $1.0 billion for Q3 2025.

  • For Q3 2025, Shares Repurchased changed N/A year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, changed 0.0%, while the annual FY2025 figure was $1.0 billion, 0.0% changed from the prior year.
  • Shares Repurchased for Q3 2025 was $1.0 billion at United Therapeutics, roughly flat from $1.0 billion in the prior quarter.
  • Across five years, Shares Repurchased topped out at $1.0 billion in Q1 2024 and bottomed at $1.0 billion in Q1 2024.